Medbanks Network Technology
Founded Year
2014Stage
IPO | IPOTotal Raised
$546.47MDate of IPO
12/23/2022About Medbanks Network Technology
Medbanks (0314.HK) is an oncology data platform in the field of cancer. It develops intelligent diagnosis and treatment systems, as well as comprehensive solutions to improve the level of tumor diagnosis and treatment and the efficiency of doctors' clinical work. The company was founded in 2014 and is based in Beijing, China.
Missing: Medbanks Network Technology's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Medbanks Network Technology's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Medbanks Network Technology
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Medbanks Network Technology is included in 4 Expert Collections, including Future Unicorns 2019.
Future Unicorns 2019
50 items
Digital Health 150
300 items
2019's cohort of the most promising digital health startups transforming the healthcare industry
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Digital Health
10,347 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest Medbanks Network Technology News
Jan 27, 2022
China News, Data, Media Intelligence and Insights Search for: Source: News Snapshot: In today’s briefing: - Contemporary Amperex Technology – King of the Overweights - Qingdao AInnovation Technology Group IPO Trading – Lukewarm Subscription Rates, Peers Have Corrected - Pre-IPO Medbanks Network Technology – Conservative About the Outlook - China Banks – Credit Quality Snapshot Ahead of 4Q21 - China Education Group (839 HK): Further Regulatory Headwinds? - Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers Before it’s here, it’s on Smartkarma
Medbanks Network Technology Frequently Asked Questions (FAQ)
When was Medbanks Network Technology founded?
Medbanks Network Technology was founded in 2014.
Where is Medbanks Network Technology's headquarters?
Medbanks Network Technology's headquarters is located at Building 17, Xinqiwang Office Building, No.1 Dongdadi Street, Dongcheng District, Beijing.
What is Medbanks Network Technology's latest funding round?
Medbanks Network Technology's latest funding round is IPO.
How much did Medbanks Network Technology raise?
Medbanks Network Technology raised a total of $546.47M.
Who are the investors of Medbanks Network Technology?
Investors of Medbanks Network Technology include Tencent, Wu Capital, 5Y Capital, Jeneration Capital, Forebright Capital Management and 8 more.
Who are Medbanks Network Technology's competitors?
Competitors of Medbanks Network Technology include Evidation.
Compare Medbanks Network Technology to Competitors
Medable operates as a global platform for decentralized clinical trials. It solves the systemic challenges inherent in modern clinical trials including access, interoperability between systems, and inefficient technology experiences. It was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.
Promptly Health is a patient empowerment focused healthcare app that helps individuals understand how they will fee after treatment, medication, or surgery.
ePHealth develops mobile solutions for primary care providers.
Datavant is dedicated to accelerating the discovery, development, and commercialization of new medicines through machine learning. It aims to partner with biomedical research institutions to eliminate silos of information and unlock insights from healthcare data. The firm was founded in 2017 and is based in San Francisco, California.
MediMergent is a data collection and analytics company focused on Real-World Data (RWD) and Real-World Evidence (RWE) related to patients’ health status. MediMergent has built and deployed a digital platform that collects RWD from customized patient surveys, medical records, health insurance claims and billing data, pharmacy prescriptions and refill data, and, where appropriate, information from wearable medical devices and apps. MediMergent combines this data, acquired directly from the patients, that relate to first-hand accounts of their perceived risk versus benefit relationship for select medications, to generate a unique set of data or evidence (RWE) related to improve outcomes and reduce costs of healthcare. Using proprietary algorithms, MediMergent produces data that can be used by the entire healthcare ecosystem including prescribers, pharmacists, health insurers, pharmaceutical companies, corporations, regulators and importantly, patients.
Neurocast offers a digital biomarker for measuring patients' performance. It helps patients, doctors, and researchers understand the course and cause of neurodegenerative disorders such as Parkinson's disease, Alzheimer’s, and depression. It was founded in 2017 and is based in Amsterdam, Netherlands.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.